https://pubmed.ncbi.nlm.nih.gov/17311250/
Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic...
The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in situ hybridization on clinical decision making has...
acute leukemiasproposalsstandardizedprotocolscytogenetic
https://scholars.uky.edu/en/publications/renal-complications-in-acute-leukemias/
Renal complications in acute leukemias - University of Kentucky
acute leukemiasuniversity ofrenalcomplicationskentucky
https://pubmed.ncbi.nlm.nih.gov/33340278/
Zebrafish models of acute leukemias: Current models and future directions
Acute myeloid leukemias (AML) and acute lymphoid leukemias (ALL) are heterogenous diseases encompassing a wide array of genetic mutations with both loss and...
current and futurezebrafish modelsacute leukemiasdirections
https://www.wikidata.org/wiki/Q51034920
Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of...
scientific article published on 21 November 2002
https://www.prnewswire.com/news-releases/gyala-therapeutics-initiates-phase-iiia-clinical-trial-of-a-car-t-cell-therapy-in-acute-leukemias-with-limited-treatment-options-302681392.html
Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias...
/PRNewswire/ -- Gyala Therapeutics, a clinical-stage biotechnology company developing innovative cell therapies for hematologic malignancies, today announced...